TCL Archive Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL April 28, 1995
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013